Microbiota reprogramming for treatment of alcohol-related liver disease

Griswold, 2018, Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 392, 1015, 10.1016/S0140-6736(18)31310-2 World Health Organization. Global Status Report on Alcohol and Health2014. Available at: https://www.who.int/substance_abuse/publications/alcohol_2014/en/. Published 2014. Accessed April 24, 2020. Axley, 2019, Epidemiology of alcohol consumption and societal burden of alcoholism and alcohol-related liver disease, Clin Liver Dis, 23, 39, 10.1016/j.cld.2018.09.011 Grant, 2017, Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on alcohol and related conditions, JAMA Psychiatry, 74, 911, 10.1001/jamapsychiatry.2017.2161 Rehm, 2017, The relationship between different dimensions of alcohol use and the burden of disease—an update, Addiction, 112, 968, 10.1111/add.13757 Gao, 2011, Alcohol-related liver disease: Pathogenesis and new therapeutic targets, Gastroenterology, 141, 1572, 10.1053/j.gastro.2011.09.002 Fuster, 2018, Alcohol use in patients with chronic liver disease, N Engl J Med, 379, 2579, 10.1056/NEJMra1715733 O'Shea, 2010, Practice guideline committee of the American Association for the study of liver D, the practice parameters committee of the American College of G. Alcohol-related liver disease, Hepatology, 51, 307, 10.1002/hep.23258 Basra, 2011, Definition, epidemiology and magnitude of alcoholic hepatitis, WJH, 3, 108, 10.4254/wjh.v3.i5.108 Jinjuvadia, 2014, Trends in alcoholic hepatitis-related hospitalizations, financial burden, and mortality in the United States, J Clin Gastroenterol, 49, 506, 10.1097/MCG.0000000000000161 Yoon YY, H. Liver cirrhosis mortality in the United States, 1970–2007. National Institute on Alcohol Abuse and Alcoholism Division of Epidemiology and Prevention Research Alcohol Epidemiologic Data System. Available at: https://pubs.niaaa.nih.gov/publications/surveillance88/Cirr07.htm. Published 2010. Accessed April 24, 2020. Saberi, 2016, Current management of alcoholic hepatitis and future therapies, J Clin Transl Hepatol, 4, 113 Hydes, 2019, Treating alcohol-related liver disease from a public health perspective, J Hepatol, 70, 223, 10.1016/j.jhep.2018.10.036 Desai, 2019, Increasing economic burden in hospitalized patients with cirrhosis: analysis of a national database, Clin Transl Gastroenterol, 10, e00062, 10.14309/ctg.0000000000000062 Stickel, 2017, Pathophysiology and management of alcohol-related liver disease: update 2016, Gut Liver, 11, 173, 10.5009/gnl16477 Mellinger, 2018, Transplantation for alcohol-related liver disease: is it fair, Alcohol Alcoholism, 53, 173, 10.1093/alcalc/agx105 Baraona, 1979, Effects of ethanol on lipid metabolism, J Lipid Res, 20, 289, 10.1016/S0022-2275(20)40613-3 You, 2019, Effect of ethanol on lipid metabolism, J Hepatol, 70, 237, 10.1016/j.jhep.2018.10.037 Zhou, 1998, Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells, Hepatology, 27, 1064, 10.1002/hep.510270423 Sanders, 2016, De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose, Biol Rev Camb Philos Soc, 91, 452, 10.1111/brv.12178 You, 2002, Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP), J Biol Chem, 277, 29342, 10.1074/jbc.M202411200 Hritz, 2008, The critical role of toll-like receptor (TLR) 4 in alcohol-related liver disease is independent of the common TLR adapter MyD88, Hepatology, 48, 1224, 10.1002/hep.22470 Yin, 1999, Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice, Gastroenterology, 117, 942, 10.1016/S0016-5085(99)70354-9 Pastorino, 2008, Tumor necrosis factor-alpha can provoke cleavage and activation of sterol regulatory element-binding protein in ethanol-exposed cells via a caspase-dependent pathway that is cholesterol insensitive, J Biol Chem, 283, 25638, 10.1074/jbc.M800237200 Lawler, 1998, Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase, J Biol Chem, 273, 5053, 10.1074/jbc.273.9.5053 Tilg, 2000, Cytokines in alcoholic and nonalcoholic steatohepatitis, N Engl J Med, 343, 1467, 10.1056/NEJM200011163432007 Zhang, 2016, Tlr4-mutant mice are resistant to acute alcohol-induced sterol-regulatory element binding protein activation and hepatic lipid accumulation, Sci Rep, 6, 33513, 10.1038/srep33513 Enomoto, 2000, Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury, J Gastroenterol Hepatol, 15, 20, 10.1046/j.1440-1746.2000.02179.x Liu, 2014, Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver, World J Gastroenterol, 20, 14672, 10.3748/wjg.v20.i40.14672 Ji, 2006, Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model, J Hepatol, 45, 717, 10.1016/j.jhep.2006.05.009 Yu, 2003, Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis, Curr Mol Med, 3, 561, 10.2174/1566524033479537 Donohue, 2009, Autophagy and ethanol-induced liver injury, WJG, 15, 1178, 10.3748/wjg.15.1178 Li, 2020, Role of mechanistic target of rapamycin and autophagy in alcohol-induced adipose atrophy and liver injury, Am J Pathol, 190, 158, 10.1016/j.ajpath.2019.09.023 Menk, 2018, Chronic alcohol consumption inhibits autophagy and promotes apoptosis in the liver, Int J Med Sci, 15, 682, 10.7150/ijms.25393 Feldstein, 2005, Apoptosis in alcoholic and nonalcoholic steatohepatitis, Front Biosci, 10, 3093, 10.2741/1765 Paik, 2006, Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid, Lab Invest, 86, 676, 10.1038/labinvest.3700422 The Human Microbiome Project, 2012, Structure, function and diversity of the healthy human microbiome, Nature, 486, 207, 10.1038/nature11234 Cresci, 2015, Gut microbiome: what we do and don't know, Nutr Clin Pract, 30, 734, 10.1177/0884533615609899 Kho, 2018, The human gut microbiome – a potential controller of wellness and disease, Front Microbiol, 9, 1835, 10.3389/fmicb.2018.01835 Schmidt, 2018, The human gut microbiome: from association to modulation, Cell, 172, 1198, 10.1016/j.cell.2018.02.044 Schnabl, 2014, Interactions between the intestinal microbiome and liver diseases, Gastroenterology, 146, 1513, 10.1053/j.gastro.2014.01.020 Sender, 2016, Revised estimates for the number of human and bacteria cells in the body, PLoS Biol, 14, 10.1371/journal.pbio.1002533 Barko, 2018, The gastrointestinal microbiome: a review, J Vet Intern Med, 32, 9, 10.1111/jvim.14875 Adolph, 2018, Liver–microbiome axis in health and disease, Trends Immunol, 39, 712, 10.1016/j.it.2018.05.002 Acharya, 2017, Microbiota, cirrhosis, and the emerging oral-gut-liver axis, JCI Insight, 2, e94416, 10.1172/jci.insight.94416 Moschen, 2013, Non-alcoholic steatohepatitis: a microbiota-driven disease, Trends Endocrinol Metab, 24, 537, 10.1016/j.tem.2013.05.009 García-Lezana, 2018, Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis: liver failure/cirrhosis/portal hypertension, Hepatology, 67, 1485, 10.1002/hep.29646 Loomba, 2019, Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease, Cell Metab, 30, 607, 10.1016/j.cmet.2019.08.002 Boursier, 2016, The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota: Boursier et al, Hepatology, 63, 764, 10.1002/hep.28356 Chiu, 2017, Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis, Nutrients, 9, 1220, 10.3390/nu9111220 Bode, 1987, Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess, J Hepatol, 4, 8, 10.1016/S0168-8278(87)80003-X Yan, 2011, Enteric dysbiosis associated with a mouse model of alcohol-related liver disease, Hepatology, 53, 96, 10.1002/hep.24018 Mutlu, 2009, Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats, Alcoholism: Clin Exp Res, 33, 1836, 10.1111/j.1530-0277.2009.01022.x Mutlu, 2012, Colonic microbiome is altered in alcoholism, Am J Physiol Gastrointest Liver Physiol, 302, G966, 10.1152/ajpgi.00380.2011 Engen, 2015, The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota, Alcohol Res, 37, 223 Guo, 2010, Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis, Fibrogen Tissue Repair, 3, 21, 10.1186/1755-1536-3-21 Ferrier, 2006, Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents, Am J Pathol, 168, 1148, 10.2353/ajpath.2006.050617 Bull-Otterson, 2013, Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment, PLoS ONE, 8, e53028, 10.1371/journal.pone.0053028 Cassard, 2018, Microbiota, a key player in alcohol-related liver disease, Clin Mol Hepatol, 24, 100, 10.3350/cmh.2017.0067 Chen, 2015, Microbiota protects mice against acute alcohol-induced liver injury, Alcoholism: Clin Exp Res, 39, 2313, 10.1111/acer.12900 Canesso, 2014, Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota, BMC Microbiol, 14, 240, 10.1186/s12866-014-0240-4 Hartmann, 2019, Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either, Am J Physiol Gastrointest Liver Physiol, 316, G563, 10.1152/ajpgi.00370.2018 Llopis, 2016, Intestinal microbiota contributes to individual susceptibility to alcohol-related liver disease, Gut, 65, 830, 10.1136/gutjnl-2015-310585 Ferrere, 2017, Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice, J Hepatol, 66, 806, 10.1016/j.jhep.2016.11.008 Ciocan, 2018, Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis, Sci Rep, 8, 4822, 10.1038/s41598-018-23146-3 Bajaj, 2019, Alcohol, liver disease and the gut microbiota, Nat Rev Gastroenterol Hepatol, 16, 235, 10.1038/s41575-018-0099-1 Chen, 2015, Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality: gut dysbiosis and liver failure, J Gastroenterol Hepatol, 30, 1429, 10.1111/jgh.12932 Smirnova, 2020, Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity, Hepatology, 72, 271, 10.1002/hep.31178 Grander, 2018, Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcohol-related liver disease, Gut, 67, 891, 10.1136/gutjnl-2016-313432 Leclercq, 2014, Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity, Proc Natl Acad Sci USA, 111, E4485, 10.1073/pnas.1415174111 Qin, 2014, Alterations of the human gut microbiome in liver cirrhosis, Nature, 513, 59, 10.1038/nature13568 Bajaj, 2014, Altered profile of human gut microbiome is associated with cirrhosis and its complications, J Hepatol, 60, 940, 10.1016/j.jhep.2013.12.019 Dubinkina, 2017, Links of gut microbiota composition with alcohol dependence syndrome and alcohol-related liver disease, Microbiome, 5, 141, 10.1186/s40168-017-0359-2 Hartmann, 2015, Alcohol-related liver disease: the gut microbiome and liver cross talk, Alcoholism: Clin Exp Res, 39, 763, 10.1111/acer.12704 Gabbard, 2014, The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth, Dig Dis Sci, 59, 638, 10.1007/s10620-013-2960-y Bode, 1993, Breath hydrogen excretion in patients with alcohol-related liver disease—evidence of small intestinal bacterial overgrowth, Z Gastroenterol, 31, 3 Adachi, 1994, Inactivation of Kupffer cells prevents early alcohol-induced liver injury, Hepatology, 20, 453, 10.1002/hep.1840200227 Adachi, 1995, Antibiotics prevent liver injury in rats following long-term exposure to ethanol, Gastroenterology, 108, 218, 10.1016/0016-5085(95)90027-6 Chen, 2015, Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcohol-related liver disease in mice, Hepatology, 61, 883, 10.1002/hep.27489 Madrid, 2001, Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function, Am J Gastroenterol, 96, 1251, 10.1111/j.1572-0241.2001.03636.x Ponziani, 2017, Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation, World J Gastroenterol, 23, 4491, 10.3748/wjg.v23.i25.4491 Kalambokis, 2012, Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia, Liver Int, 32, 467, 10.1111/j.1478-3231.2011.02650.x Wiest, 2017, Targeting the gut-liver axis in liver disease, J Hepatol, 67, 1084, 10.1016/j.jhep.2017.05.007 Perttu Sahlman M.Randomised open-label multicenter study evaluating ciprofloxacin in severe alcoholic hepatitis: clinical trial: NCT02326103. Available at: https://clinicaltrials.gov/ct2/show/NCT02326103. Published 2017. Accessed April 24, 2020. Mathurin Philippe M.Efficacy of antibiotic therapy in severe alcoholic hepatitis treated with prednisolone (AntibioCor): clinical trial: NCT02281929. Available at: https://clinicaltrials.gov/ct2/show/NCT02281929. Published 2019. Accessed April 24, 2020. Dethlefsen, 2008, The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing, PLoS Biol, 6, e280, 10.1371/journal.pbio.0060280 Bindels, 2015, Towards a more comprehensive concept for prebiotics, Nat Rev Gastroenterol Hepatol, 12, 303, 10.1038/nrgastro.2015.47 Cresci, 2020, Targeted approaches for in situ gut microbiome manipulation, JPEN J Parenter Enteral Nutr, 44, 581, 10.1002/jpen.1779 Keshavarzian, 2001, Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats, J Pharmacol Exp Ther, 299, 442 Lam, 2013, Non-digestible long chain beta-glucans as novel prebiotics, Bioactive Carbohydr Dietary Fibre, 2, 45, 10.1016/j.bcdf.2013.09.001 Tang, 2009, Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage, J Pharmacol Exp Ther, 329, 952, 10.1124/jpet.108.148643 Bothe, 2017, Dose-dependent prebiotic effect of lactulose in a computer-controlled in vitro model of the human large intestine, Nutrients, 9, 767, 10.3390/nu9070767 Watanabe, 1997, Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy, Hepatology, 26, 1410, 10.1002/hep.510260606 Bermudez-Brito, 2012, Probiotic mechanisms of action, Ann Nutr Metab, 61, 160, 10.1159/000342079 Nanji, 1994, Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease), Exp Biol Med, 205, 243, 10.3181/00379727-205-43703 Wang, 2011, Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury, Am J Pathol, 179, 2866, 10.1016/j.ajpath.2011.08.039 Wang, 2013, Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury, J Nutr Biochem, 24, 1609, 10.1016/j.jnutbio.2013.02.001 Yan, 2007, Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth, Gastroenterology, 132, 562, 10.1053/j.gastro.2006.11.022 Chen, 2016, Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances T reg and T H 17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding, Toxicol Lett, 241, 103, 10.1016/j.toxlet.2015.11.019 Zhang, 2015, Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease, J Nutr Biochem, 26, 337, 10.1016/j.jnutbio.2014.10.016 Zhao, 2015, Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcohol-related liver disease, Toxicol Lett, 234, 194, 10.1016/j.toxlet.2015.03.002 Chang, 2013, The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury, BMC Gastroenterol, 13, 151, 10.1186/1471-230X-13-151 Han, 2015, Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study, Eur J Gastroenterol Hepatol, 27, 1300, 10.1097/MEG.0000000000000458 Kirpich, 2008, Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study, Alcohol, 42, 675, 10.1016/j.alcohol.2008.08.006 Stadlbauer, 2008, Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis, J Hepatol, 48, 945, 10.1016/j.jhep.2008.02.015 Loguercio, 2005, Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases, J Clin Gastroenterol, 39, 540, 10.1097/01.mcg.0000165671.25272.0f Velázquez, 1996, Butyrate and the colonocyte: implications for neoplasia, Digest Dis Sci, 41, 727, 10.1007/BF02213129 Bach Knudsen, 2018, Impact of diet-modulated butyrate production on intestinal barrier function and inflammation, Nutrients, 10, 1499, 10.3390/nu10101499 Bartholome, 2004, Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets, JPEN J Parenter Enteral Nutr, 28, 210, 10.1177/0148607104028004210 Weaver, 1988, Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer, Gut, 29, 1539, 10.1136/gut.29.11.1539 Lundquist, 1962, Ethanol metabolism and the production of free acetate in human liver, J Clin Invest, 41, 955, 10.1172/JCI104574 Fujimiya, 1999, Michaelis-Menton elimination kinetics of acetate in rabbit, Alcohol: Clin Exp Res, 23, 1452, 10.1111/j.1530-0277.1999.tb04666.x Carmichael, 1991, Central nervous system effects of acetate: contribution to the central effects of ethanol, J Pharmacol Exp Ther, 259, 403 Xie, 2013, Chronic ethanol consumption alters mammalian gastrointestinal content metabolites, J Proteome Res, 12, 3297, 10.1021/pr400362z Cresci, 2014, Tributyrin supplementation protects mice from acute ethanol-induced gut injury, Alcohol Clin Exp Res, 38, 1489, 10.1111/acer.12428 Cresci, 2017, Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury, J Gastroenterol Hepatol, 32, 1587, 10.1111/jgh.13731 Glueck, 2018, Tributyrin supplementation protects immune responses and vasculature and reduces oxidative stress in the proximal colon of mice exposed to chronic-binge ethanol feeding, J Immunol Res, 2018, 10.1155/2018/9671919 Donde, 2019, Tributyrin inhibits ethanol-induced epigenetic repression of CPT-1A and attenuates hepatic steatosis and injury, Cell Mol Gastroenterol Hepatol, 9, 569, 10.1016/j.jcmgh.2019.10.005 Rishi, 2017, Better management of alcohol liver disease using a 'microstructured synbox' system comprising L. plantarum and EGCG, PLoS ONE, 12, 10.1371/journal.pone.0168459 Roychowdhury, 2019, A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice, Nutrients, 11, 97, 10.3390/nu11010097 Han, 2020, Dietary synbiotic supplementation protects barrier integrity of hepatocytes and liver sinusoidal endothelium in a mouse model of chronic-binge ethanol exposure, Nutrients, 12, 373, 10.3390/nu12020373 Sittiprapaporn, 2020, The effect of synbiotics supplement on alcohol use disorders identification test and biochemical parameters, gamma glutamyl transferase, lipopolysaccharide and immunoglobulin a levels, in high risk alcoholics, Asian J Med Sci, 11, 1, 10.3126/ajms.v11i1.26497 Figueroa-Gonzalez, 2011, Probiotics and prebiotics—perspectives and challenges, J Sci Food Agric, 91, 1341, 10.1002/jsfa.4367 Venugopalan, 2010, Regulatory oversight and safety of probiotic use, Emerg Infect Dis, 16, 1661, 10.3201/eid1611.100574 Center for Food Safety and Applied Nutrition. Complementary and Alternative Medicine Products and their Regulation by the Food and Drug Administration: Guidance Document. U.S. F.D.A. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/complementary-and-alternative-medicine-products-and-their-regulation-food-and-drug-administration. Accessed June 6, 2020. WGO Review Team. World Gastroenterology Organisation (WGO): global guidelines on probiotics and prebiotics. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/probiotics-and-prebiotics-english-2017.pdf. Accessed June 7, 2020. Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans: FDA Statement. Available at:https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-advancing-science-and-regulation-live-microbiome-based. Published 2018. Accessed June 7, 2020. Borody, 2013, Fecal microbiota transplantation: indications, methods, evidence, and future directions, Curr Gastroenterol Rep, 15, 337, 10.1007/s11894-013-0337-1 Philips, 2017, Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis, BMJ Case Rep, 2017 Philips, 2018, Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis, Indian J Gastroenterol, 37, 215, 10.1007/s12664-018-0859-4 Lee, 2018, Targeted approaches for in situ gut microbiome manipulation, Genes (Basel), 9, 351, 10.3390/genes9070351 Duan, 2015, Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes, Diabetes, 64, 1794, 10.2337/db14-0635 Martin, 2014, Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation, Hum Vaccin Immunother, 10, 1611, 10.4161/hv.28549 Hendrikx, 2019, Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice, Gut, 68, 1504, 10.1136/gutjnl-2018-317232 Chan, 2018, Phage treatment of an aortic graft infected with Pseudomonas aeruginosa, Evol Med Public Health., 2018, 60, 10.1093/emph/eoy005 Schooley, 2017, Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection, Antimicrob Agents Chemother, 61, 10.1128/AAC.00954-17 Kortright, 2019, Phage therapy: a renewed approach to combat antibiotic-resistant bacteria, Cell Host Microbe, 25, 219, 10.1016/j.chom.2019.01.014 Nakamoto, 2019, Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis, Nat Microbiol, 4, 492, 10.1038/s41564-018-0333-1 Duan, 2019, Bacteriophage targeting of gut bacterium attenuates alcohol-related liver disease, Nature, 575, 505, 10.1038/s41586-019-1742-x